Literature DB >> 2001037

Cerebral uptake and elimination of desflurane, isoflurane, and halothane from rabbit brain: an in vivo NMR study.

S H Lockhart1, Y Cohen, N Yasuda, B Freire, S Taheri, L Litt, E I Eger.   

Abstract

The authors used in vivo 19F nuclear magnetic resonance spectroscopy to determine rates of cerebral uptake and elimination of desflurane, isoflurane, and halothane in rabbits. After anesthetizing animals by intramuscular and intravenous injection of methohexital and inhalation of 70% nitrous oxide, intravenous and intraarterial catheters were inserted and a tracheostomy and craniotomy performed. Ventilation was controlled to maintain arterial carbon dioxide tension (PaCO2) from between 35 and 45 mmHg. A 2-2.5-cm diameter circle of dura was exposed, over which a 0.9 x 1.0-cm elliptical surface coil was placed. Cerebral anesthetic concentrations (CC) were estimated from spectra acquired on a 4.7-Tesla spectrometer. Alveolar uptake and elimination also were assessed, using inspired (FI) and end-tidal (denoted FA0 at the end of administration) concentrations measured by gas chromatography. After baseline spectra were obtained, volatile agents were administered for 30 min, followed by a 120-min period of elimination. Our findings demonstrate that cerebral uptake and elimination correlate with solubility: they are most rapid for desflurane, next most rapid for isoflurane, and least rapid for halothane. During administration, cerebral uptake of desflurane (CC/FI = 0.690 +/- 0.049 at 9 min) was approximately 1.7 times faster than isoflurane (CC/FI = 0.691 +/- 0.020 at 15 min) and 3 times faster than halothane (CC/FI = 0.662 +/- 0.040 at 27 min). Similarly, elimination rates for desflurane (CC/FA0 = 0.238 +/- 0.015 at 9 min) were 1.7 times faster than isoflurane (CC/FA0 = 0.236 +/- 0.017 at 15 min) and three times faster than halothane (CC/FA0 = 0.212 +/- 0.033 at 27 min).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001037     DOI: 10.1097/00000542-199103000-00028

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Measurement of anesthetic uptake kinetics in the brain using (19)F MRI and cross-correlation analysis after pulsed application.

Authors:  Maxim Terekhov; Alexander Scholz; Laura M Schreiber
Journal:  MAGMA       Date:  2013-06-13       Impact factor: 2.310

2.  Comparative pharmacodynamic modeling of desflurane, sevoflurane and isoflurane.

Authors:  Sascha Kreuer; Jörgen Bruhn; Wolfram Wilhelm; Ulrich Grundmann; Hauke Rensing; Stefan Ziegeler
Journal:  J Clin Monit Comput       Date:  2009-08-27       Impact factor: 2.502

3.  A chemical shift encoding (CSE) approach for spectral selection in fluorine-19 MRI.

Authors:  Kai D Ludwig; Diego Hernando; Nathan T Roberts; Ruud B van Heeswijk; Sean B Fain
Journal:  Magn Reson Med       Date:  2017-08-22       Impact factor: 4.668

4.  Assessment of Common Criteria for Awake Extubation in Infants and Young Children.

Authors:  T Wesley Templeton; Eduardo J Goenaga-Díaz; Martina G Downard; Christopher J McLouth; Timothy E Smith; Leah B Templeton; Shelly H Pecorella; Dudley E Hammon; James J O'Brien; Douglas H McLaughlin; Ann E Lawrence; Phillip R Tennant; Douglas G Ririe
Journal:  Anesthesiology       Date:  2019-10       Impact factor: 7.892

Review 5.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 6.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

7.  Extending the Scope of 19F Hyperpolarization through Signal Amplification by Reversible Exchange in MRI and NMR Spectroscopy.

Authors:  Alexandra M Olaru; Thomas B R Robertson; Jennifer S Lewis; Alex Antony; Wissam Iali; Ryan E Mewis; Simon B Duckett
Journal:  ChemistryOpen       Date:  2017-12-21       Impact factor: 2.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.